Human papilloma virus is linked to the cancer of cervix in female. Vaccination against it may be an attempt to make the male free from the disease which may also prevent its spread to female partner. Also it will prevent the papilloma in male.
WASHINGTON -- The FDA approved Merck's Gardasil vaccine against human papillomavirus (HPV) for boys and men, the same day that it okayed a competing vaccine for use in females. Gardasil was approved for males ages 9 to 26 for prevention of genital warts. The approval did not address claims that the vaccine in this population may help prevent transmission to girls and women. The new indication for Gardasil was based on two trials: a randomized trial in 4,055 males ages 16 through 26 testing the vaccine's effectiveness in preventing genital warts, and a study in boys ages 9 to 15 that measured immune responses. The second trial showed that the immune response was as good as that found in the older age group, indicating that the vaccine should have similar effectiveness, the FDA said. |